A 5-fluorodeoxyuridine prodrug as targeted therapy for prostate cancer

Cancer Statistics, 2002

Ahmedin Jemal, Anish Thomas, Thomas S. Murray et al. · CA A Cancer Journal for Clinicians · 2002 · 2.9K citations · Full text

American Cancer Society, Cancer Statistics, Epidemiology +12

Implication of cell kinetic changes during the progression of human prostatic cancer.

R. Berges, Jasminka Vukanovic, Jonathan I. Epstein et al. · PubMed · 1995 · 346 citations

Tumor Biology, Daily Percentage, Urology +15

Maximum androgen blockade in advanced prostate cancer: an overview of 22 randomised trials with 3283 deaths in 5710 patients

Prostate Cancer Trialists' Collaborative Group · The Lancet · 1995 · 285 citations

Urology, Genitourinary Cancer, Medicine +11

MAXIMUM ANDROGEN BLOCKADE IN ADVANCED PROSTATE-CANCER - AN OVERVIEW OF 22 RANDOMIZED TRIALS WITH 3283 DEATHS IN 5710 PATIENTS

Otilia Dalesio, H. vanTinteren, L. Denis et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1995 · 234 citations

Urology, Genitourinary Cancer, Medicine +9

Specific and efficient peptide substrates for assaying the proteolytic activity of prostate-specific antigen.

Samuel R. Denmeade, Wei Lou, Janita Lövgren et al. · PubMed · 1997 · 192 citations

Efficient Peptide Substrates, Urology, Biochemistry +15